Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast CancerOlivia Pagani, Prudence A. Francis, Thomas Ruhstaller et al.|New England Journal of Medicine|2014Cited by 751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast CancerPrudence A. Francis, Meredith M. Regan, Olivia Pagani et al.|New England Journal of Medicine|2018Cited by 684
Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III TrialPaul E. Goss, Lois E. Shepherd, James N. Ingle et al.|Journal of Clinical Oncology|2013Cited by 261
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT TrialsOlivia Pagani, Prudence A. Francis, Barbara Walley et al.|Journal of Clinical Oncology|2022Cited by 159
Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFTOlivia Pagani, Prudence A. Francis, Gini F. Fleming et al.|Journal of Clinical Oncology|2019Cited by 150